痛風病治療市場按藥物類別、疾病類型、通路、給藥途徑和地區分類

2025年全球痛風病治療市場規模估計為30.4億美元，預計到2032年將達到53.2億美元，2025年至2032年的複合年成長率為8.3%。

數字。 2025 年痛風病治療市場佔有率（按地區分類）

痛風病是一種常見的發炎性關節炎，由關節（通常是拇趾滑液囊炎）中尿酸結晶的堆積引起。痛風會導致一個或多個關節突然出現劇烈的疼痛、腫脹和壓痛。已開發國家酒精消費量的增加、肥胖率和人口老化導致全球痛風盛行率上升。隨著越來越多的治療選擇的出現以及人們對尿酸管理以預防痛風發作的認知的提高，全球痛風病治療市場可能會成長。

市場動態

全球痛風病治療市場的成長是由於全球老年人口的增加（他們更容易患上痛風）、肥胖率的上升導致痛風風險的增加，以及酒精和高嘌呤食物消費量的增加。此外，人們對早期診斷和治療痛風以防止關節損傷的認知不斷提高、新興市場人均醫療支出的增加以及新產品的核准都是推動市場成長的一些因素。然而，Allopurinol的非專利競爭、藥物副作用以及患者不依從性可能會阻礙市場的成長。具有新的治療標靶和更佳安全性的在研藥物的開發可以為市場參與企業提供豐厚的機會。

研究的主要特點

• 本報告對全球痛風治療市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。
• 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球痛風病治療市場的主要企業概況。
• 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球痛風病治療市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 透過全球痛風病治療市場分析中使用的各種策略矩陣，相關人員將更容易做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

4. 全球痛風治療市場-冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 2020 年至 2032 年全球痛風病治療市場（按藥物類別分類）（十億美元）

• 介紹
• NSAIDs
• 皮質類固醇
• 秋水仙鹼
• 降尿酸藥物
• 其他

6. 2020-2032 年全球痛風病治療市場（按疾病類型分類）（十億美元）

• 介紹
• 急性痛風
• 慢性痛風

7. 2020-2032 年全球痛風治療市場按通路分類（十億美元）

• 介紹
• 醫院藥房
• 零售藥局
• 專業藥房

8. 2020 年至 2032 年按給藥途徑分類的全球痛風病治療市場（十億美元）

• 介紹
• 口服
• 腸外

9. 2020 年至 2032 年全球痛風病治療市場（按地區分類）（十億美元）

• 介紹
• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第10章 競爭格局

• 公司簡介
  • Takeda Pharmaceutical Company Ltd.
  • Novartis AG
  • Regeneron Pharmaceuticals Inc.
  • AstraZeneca plc
  • Horizon Therapeutics plc
  • Merck &Co. Inc.
  • Teijin Pharma Ltd.
  • GlaxoSmithKline, Plc.
  • Zydus Group
  • Menarini Group
  • JW Pharmaceutical
  • Simcere Pharmaceutical Group
  • Ionis Pharmaceuticals, Inc.
  • Selecta Biosciences
  • Mylan NV

第 11 章 分析師建議

• 興衰
• 一致的機會地圖

第 12 章參考文獻與調查方法

• 參考
• 調查方法

Global Gout Disease Treatment Market is estimated to be valued at USD 3.04 Bn in 2025 and is expected to reach USD 5.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.

Figure. Gout Disease Treatment Market Share (%), By Region 2025

Gout disease is a common form of inflammatory arthritis that occurs when uric acid crystals accumulate in the joints, typically in the big toe. It causes sudden and severe attacks of pain, swelling and tenderness in one or more joints. Rising consumption of alcohol, obesity rates and aging populations in developed nations have contributed to increase in gout prevalence globally. Global gout disease treatment market can witness growth as more treatment options become available and awareness increases about managing uric acid levels to prevent gout flares.

Market Dynamics:

Global gout disease treatment market growth is driven by growing geriatric population globally who are more prone to develop gout, rising obesity rates leading to higher risk of gout, increasing consumption of alcohol and purine-rich foods. Moreover, growing awareness about early diagnosis and treatment of gout to prevent joint damage, rising per capita healthcare expenditure in developing countries and new product approvals can drive the market growth. However, generic competition for allopurinol, side effects of drugs and patient non-adherence can hamper the market growth. The development of novel treatment targets and pipeline drugs with improved safety profiles can provide lucrative opportunities for market players.

Key Features of the Study:

• This report provides in-depth analysis of the global gout disease treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global gout disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Takeda Pharmaceutical, Novartis, AstraZeneca, Teijin Pharma, Mylan, and Horizon Therapeutics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global gout disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gout disease treatment market

Detailed Segmentation-

• By Drug Class
  • NSAIDs
  • Corticosteroids
  • Colchicine
  • Urate-Lowering Agents
  • Others
• By Disease Type
  • Acute Gout
  • Chronic Gout
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
• By Route Of administration
  • Oral
  • Parentral
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Takeda Pharmaceutical Company Ltd.
  • Novartis AG
  • Regeneron Pharmaceuticals Inc.
  • AstraZeneca plc
  • Horizon Therapeutics plc
  • Merck & Co. Inc.
  • Teijin Pharma Ltd.
  • GlaxoSmithKline, Plc.
  • Zydus Group
  • Menarini Group
  • JW Pharmaceutical
  • Simcere Pharmaceutical Group
  • Ionis Pharmaceuticals, Inc.
  • Selecta Biosciences
  • Mylan N.V.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Disease Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Gout Disease Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Gout Disease Treatment Market, By Drug Class, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• NSAIDs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Corticosteroids
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Colchicine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Urate-Lowering Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Gout Disease Treatment Market, By Disease Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Acute Gout
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Gout
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Gout Disease Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Gout Disease Treatment Market, By Route Of administration, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parenteral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Gout Disease Treatment Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USDBn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Takeda Pharmaceutical Company Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Regeneron Pharmaceuticals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Horizon Therapeutics plc
  • Merck & Co. Inc.
  • Teijin Pharma Ltd.
  • GlaxoSmithKline, Plc.
  • Zydus Group
  • Menarini Group
  • JW Pharmaceutical
  • Simcere Pharmaceutical Group
  • Ionis Pharmaceuticals, Inc.
  • Selecta Biosciences
  • Mylan N.V.

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact